GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms

Clinical trial NCT07306156 · RECRUITING

Trial details

NCT number: NCT07306156
Sponsor: Zhimin Zhai
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EBV Associated Lymphoid Neoplasms

Start date: 2025-11-10
Primary completion: 2030-11-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.